Seize the $100B Precision Medicine Opportunity in Suzhou This May: Industry Leaders, Unicorns, and Top-Tier Investors Gather
With breakthroughs in gene sequencing technology and the maturation of molecular biology, precision medicine has gradually become a key direction in modern medicine. At its core, precision medicine leverages molecular diagnostic technologies to enable early disease warning, precise diagnosis, and personalized treatment, thereby improving therapeutic outcomes and patient survival rates. As a critical component of precision medicine, molecular diagnostics has experienced rapid development worldwide in recent years. In China, in particular, the molecular diagnostics market underwent a period of rapid growth from 2010 to 2014 and has continued to maintain a high growth trajectory in the subsequent years.
Despite positive development trends, the advancement of molecular diagnostics faces several challenges, including high costs, insufficient standardization, excessive specialization, low rates of clinical translation, and issues related to data interpretation and privacy protection.
To help industry practitioners better understand the industrial development ecosystem, and to facilitate high-quality exchanges on corporate pain points and explore potential solutions,The 2025 VBEF Top 100 Future Healthcare and Pharmaceuticals Exhibition (VBEF), held on May 9–10, will concurrently host the “Forum on the Development of Precision Medicine and Molecular Diagnostics Industry.”, inviting experts and scholars from the industry, innovative enterprises, investment institutions, and others to attend. The event will feature in-depth discussions on cutting-edge technologies, achievement transformation, and industrial innovation in the fields of precision medicine and molecular diagnostics, aiming to foster exchange and collaboration among industry, academia, research, and investment sectors, and jointly promote the development of the precision medicine and molecular diagnostics industries.
From single-molecule biosensing technologies from a clinical perspective, to the cutting-edge applications of molecular diagnostics, liquid biopsy, and genetic testing from an industry chain perspective, and further to the construction of an industrial ecosystem from an ecological perspective, the integration of multiple perspectives helps attendees comprehensively understand the current status and development trends of precision medicine, providing all participants with comprehensive insights ranging from technology to market, and from policy to industrial layout.
Multiple sessions in the agenda focused on the clinical translation of cutting-edge technologies, such as single-molecule biosensing and liquid biopsy techniques to facilitate stratified diagnosis and treatment of minimal residual disease (MRD). These sessions not only showcased the latest technological advancements but also emphasized their application in clinical practice to address practical issues, including improving the quality of life for cancer patients. This deep integration helps align technological innovation with clinical needs, accelerating the implementation of precision medicine technologies.
Experts from West China Hospital of Sichuan University, molecular diagnostics companies, gene sequencing firms, and respiratory testing enterprises were invited.Representatives from clinical institutions, enterprises, industrial parks, and investment firms,The diverse lineup of guests provides a platform for in-depth industry exchanges, particularly during the roundtable discussions, where participants will jointly explore the opportunities and challenges in precision diagnosis and treatment, promote the collaborative development of industry, academia, research, and application, and advance the ecosystem building of the precision medicine industry.
May 10, 14:00–17:00
(The following is a tentative schedule; please refer to the on-site arrangements for details.)
14：00-14：20
"Single-Molecule Biosensing Technology and Innovative Diagnostics"
Geng Jia | Deputy Director, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University
14：20-14：40
“Development and Application of Molecular Diagnostics and Personalized Therapy in Oncology” (proposed)
Representative of Molecular Diagnostics Companies
14：40-15：00
“Frontier Trends in Liquid Biopsy Technology: Personalized Panels Facilitate Stratified Diagnosis and Treatment of MRD, Improving the Quality of Life for Cancer Patients” (Proposed)
Representative of MRD Diagnostic Companies
15：00-15：20
"Policy Differences and Conversion Pathways Between LDTs and IVDs"
Representatives of Gene Sequencing Companies / IVD (In Vitro Diagnostics) Enterprises / Medical Device Manufacturers
15：20-15：40
“Advances in Genetic Testing Technology and Clinical Applications” (proposed)
Representative of Genetic Testing Companies
15：40-16：00
"Innovations and Breakthroughs in the Field of Breath Analysis" (Proposed)
Representative of a Breath Analysis Company
16：00-16：40
“Innovations and Breakthroughs in the Field of Breath Analysis” (Proposed)
Representative of a Breath Analysis Company
16：40-17：00
"Building the Ecosystem of the Precision Medicine Industry" (Proposed)
Representatives of Industrial Parks/Investment Institutions
17：00-17：40
Roundtable Discussion: Opportunities and Challenges in Precision Diagnosis and Treatment
Dialogue Guests: Deneng Medical, etc.
Event Agenda:
1. Share this post to your WeChat Moments (set visibility to public, no group restrictions);
2. Keep the tweet for 1 hour and collect 18 likes on WeChat Moments;
3. Add the customer service WeChat account and send the screenshot;
4. Obtain a complimentary conference ticket valued at RMB 399;
Event Agenda:
1. Your company is an upstream or downstream enterprise in the fields of precision medicine and molecular diagnostics;
2. Add the customer service WeChat account and provide your personal business card;
3. Obtain a complimentary conference ticket worth 399 yuan;
(Choose One of Two Promotional Offers)
Scan the QR code below to participate in the promotional event for the “Precision Medicine and Molecular Diagnostics Industry Development Forum” and contact the organizing committee to obtain tickets!
